•
Jun 30, 2022
TELA Bio Q2 2022 Earnings Report
Reported revenue increase of 38% compared to the prior year period.
Key Takeaways
TELA Bio reported a revenue of $10.4 million for the second quarter of 2022, representing a 38% increase compared to the prior year period. The company's gross profit was $6.6 million, or 63% of revenue. The net loss for the quarter was $12.7 million, and the company's cash and cash equivalents totaled $27.7 million.
Revenue was $10.4 million, an increase of 38% compared to the prior year period.
Gross profit was $6.6 million, or 63% of revenue.
Operating expenses were $16.8 million.
Net loss was $12.7 million.
TELA Bio
TELA Bio
Forward Guidance
TELA Bio expects full year 2022 revenue to range from $42 million to $45 million, reflecting growth of 43% to 53% over full year 2021.
Challenges Ahead
- A higher-than-expected impact from the COVID-19 pandemic in the back half of the year could materially affect this projection.